Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Knowing when to report business credit card rewards to the IRS helps you stay compliant and avoid potential penalties. Get the insights you need here.
18,688 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A high-profile trademark dispute around the 1587 Prime restaurant tests more than litigation—it tests how branding, c...
Buffett’s longest-running wager sits in plain sight: a simple, legendary drink that built a fortress around its brand...
As the U.S. ramps up nuclear capacity, one stock could benefit from policy shifts, domestic fuel security, and growin...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
A high-profile insider sale can shake investor nerves. This guide explains what the Dropbox stock sell after event mi...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
A fresh look at SpaceX after its IPO reveals how investors price a company with rockets and recurring revenue. This w...
Netflix's latest earnings shook investors, sending the stock below $70. This article weighs the risks and opportuniti...
In 2026, Palantir and Sandisk both delivered blowout earnings, but their stock moves told different stories. This art...
As markets heat up this summer, here's this tech stock stands out for its AI-focused growth story, solid finances, an...
A Milwaukee case shows how a real estate influencer pulled in millions with promises of fix-and-flip profits, then us...